News and Trends 13 Jul 2020
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
…Kiadis’ CEO Arthur Lahr told me that antibody drugs can be made to mark cancer cells. Natural killer cells then swoop in, recognize the antibodies, and kill the marked tumor…